Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion

Stroke

Volumn 42, Issue 4, 2011, Pages 1097-1104

  Miyazaki, Takuro ^a   Kimura, Yuji ^a   Ohata, Hisayuki ^a   Hashimoto, Terumasa ^a   Shibata, Keita ^a   Hasumi, Keiji ^b   Honda, Kazuo ^a  

^a SHOWA UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

endothelium; focal ischemia; SMTP 7; thrombolysis; tPA; vasculitis

Indexed keywords

ALTEPLASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOLYTIC AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; STACHYBOTRYS MICROSPORA TRIPRENYL PHENOL 7; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN PERFUSION; BRAIN VEIN; CELL ADHESION; CELL INTERACTION; CEREBROVASCULAR DISEASE; CEREBROVASCULAR INFLAMMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRINOLYTIC THERAPY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; LEUKOCYTE ROLLING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION; VASCULITIS;

ANIMALS; BENZOPYRANS; CELL LINE, TUMOR; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; INTRACRANIAL EMBOLISM; LASERS; MALE; MICE; PYRROLIDINONES; REPERFUSION INJURY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79954590456     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.598359     Document Type: Article

References (19)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Yepes M, Roussel BD, Ali C, Vivien D. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci. 2009;32:48-55.
3. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med. 1998; 4:228-231. (Pubitemid 28138083)
4. Cheng T, Petraglia AL, Li Z, Thiyagarajan M, Zhong Z, Wu Z, et al. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med. 2006;12:1278-1285. (Pubitemid 44706930)
5. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184:53-68. (Pubitemid 46365991)
6. Yilmaz G, Granger DN. Leukocyte Recruitment and Ischemic Brain Injury. Neuromolecular Med. 2010;12:193-204.
7. Zhang RL, Zhang ZG, Chopp M, Zivin JA. Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain. Stroke. 1999;30:624-629. (Pubitemid 29115402)
8. Chopp M, Li Y, Jiang N, Zhang RL, Prostak J. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab. 1996;16:578-584. (Pubitemid 26227066)
9. Hu W, Ohyama S, Hasumi K. Activation of fibrinolysis by SMTP-7 and-8, novel staplabin analogs with a pseudosymmetric structure. J Antibiot (Tokyo). 2000;53:241-247. (Pubitemid 30199075)
10. Hashimoto T, Shibata K, Nobe K, Hasumi K, Honda K. A novel embolic model of cerebral infarction and evaluation of SMTP-7, a novel fungal triprenyl phenol metabolite. J Pharmacol sci. 2010;114:41-49.
11. Shibata K, Hashimoto T, Nobe K, Hasumi K, Honda K. A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice. Naunyn Schmiedebergs Arch Pharmacol. 2010;382:245-253.
12. Ding S, Wang T, Cui W, Haydon PG. Photothrombosis ischemia stimulates a sustained astrocytic Ca2+ signaling in vivo. Glia. 2009;57: 767-776.
13. Miyazaki T, Honda K, Ohata H. m-Calpain antagonizes RhoA overactivation and endothelial barrier dysfunction under disturbed shear conditions. Cardiovasc Res. 2010;85:530-541.
14. Miyazaki T, Honda K, Ohata H. Requirement of Ca2+ influx-and phosphatidylinositol 3-kinase-mediated m-calpain activity for shear stressinduced endothelial cell polarity. Am J Physiol Cell Physiol. 2007;293: C1216-C1225. (Pubitemid 47556733)
15. Theriault A, Chao JT, Gapor A. Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis. 2002;160:21-30. (Pubitemid 34076642)
16. Mishima K, Tanaka T, Pu F, Egashira N, Iwasaki K, Hidaka R, et al. Vitamin E isoforms alpha-tocotrienol and gamma-tocopherol prevent cerebral infarction in mice. Neurosci Lett. 2003;337:56-60. (Pubitemid 36078309)
17. Godfrey KR, Tanswell P, Bates RA, Chappell MJ, Madden FN. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species: a comparison of mathematical models. Biopharm Drug Dispos. 1998;19:131-140. (Pubitemid 28114327)
18. Tejima E, Katayama Y, Suzuki Y, Kano T, Lo EH. Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model. Stroke. 2001;32:1336-1340. (Pubitemid 32530419)
19. Hiu T, Nakagawa S, Hayashi K, Kitagawa N, Tsutsumi K, Kawakubo J, et al. Tissue plasminogen activator enhances the hypoxia/reoxygenationinduced impairment of the blood-brain barrier in a primary culture of rat brain endothelial cells. Cell Mol Neurobiol. 2008;28:1139-1146.